UNIVERSITY OF MICHIGAN PHASE 1/2 CLINICAL TRIALS ASSESSMENT IN KIDNEY CANCER THERAPEUTICS (U-MPAKT)

$1,248,000FY2024Defense Health AgencyDOD

Regents Of The University Of Michigan

Investigators